A Macrophage Sterol-Responsive Network Linked to Atherogenesis

Cell Metabolism

Volumn 11, Issue 2, 2010, Pages 125-135

  Becker, Lev ^a   Gharib, Sina A ^a   Irwin, Angela D ^a   Wijsman, Ellen ^a   Vaisar, Tomas ^a   Oram, John F ^a   Heinecke, Jay W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

HUMDISEASE

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL ESTER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN RECEPTOR; ROSIGLITAZONE; SIMVASTATIN; STEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL FUNCTION; CELL TRANSFORMATION; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG SCREENING; FOAM CELL; IN VIVO STUDY; LIPID STORAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; STEROL ANALYSIS; VASCULAR DISEASE;

ANIMALS; ANTILIPEMIC AGENTS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; FOAM CELLS; GENE EXPRESSION REGULATION; HYPOGLYCEMIC AGENTS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; PROTEINS; RECEPTORS, LDL; SIMVASTATIN; STEROLS; THIAZOLIDINEDIONES;

MUS;

EID: 75149150355     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2010.01.003     Document Type: Article

References (42)

1. Ait-Oufella H., Kinugawa K., Zoll J., Simon T., Boddaert J., Heeneman S., Blanc-Brude O., Barateau V., Potteaux S., Merval R., et al. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation 115 (2007) 2168-2177
2. Babaev V.R., Patel M.B., Semenkovich C.F., Fazio S., and Linton M.F. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice. J. Biol. Chem. 275 (2000) 26293-26299
3. Becker K.G., Hosack D.A., Dennis Jr. G., Lempicki R.A., Bright T.J., Cheadle C., and Engel J. PubMatrix: a tool for multiplex literature mining. BMC Bioinformatics 4 (2003) 61
4. Bellosta S., Mahley R.W., Sanan D.A., Murata J., Newland D.L., Taylor J.M., and Pitas R.E. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96 (1995) 2170-2179
5. Bengtsson E., To F., Håkansson K., Grubb A., Brånén L., Nilsson J., and Jovinge S. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2151-2156
6. Benjamini Y., and Hochberg Y. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J. R. Stat. Soc., B 57 (1995) 289-300
7. Brown M.S., and Goldstein J.L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52 (1983) 223-261
8. Brown M.S., and Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 232 (1986) 34-47
9. Buono C., Come C.E., Witztum J.L., Maguire G.F., Connelly P.W., Carroll M., and Lichtman A.H. Influence of C3 deficiency on atherosclerosis. Circulation 105 (2002) 3025-3031
10. Calvano S.E., Xiao W., Richards D.R., Felciano R.M., Baker H.V., Cho R.J., Chen R.O., Brownstein B.H., Cobb J.P., Tschoeke S.K., et al., Inflamm and Host Response to Injury Large Scale Collab. Res. Program. A network-based analysis of systemic inflammation in humans. Nature 437 (2005) 1032-1037
11. Chen Y., Zhu J., Lum P.Y., Yang X., Pinto S., MacNeil D.J., Zhang C., Lamb J., Edwards S., Sieberts S.K., et al. Variations in DNA elucidate molecular networks that cause disease. Nature 452 (2008) 429-435
12. Chen Z., Fukutomi T., Zago A.C., Ehlers R., Detmers P.A., Wright S.D., Rogers C., and Simon D.I. Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids. Circulation 106 (2002) 20-23
13. Cocucci E., Racchetti G., and Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 19 (2009) 43-51
14. de Luca C., and Olefsky J.M. Inflammation and insulin resistance. FEBS Lett. 582 (2008) 97-105
15. Feil S., Hofmann F., and Feil R. SM22alpha modulates vascular smooth muscle cell phenotype during atherogenesis. Circ. Res. 94 (2004) 863-865
16. Fu X., Gharib S.A., Green P.S., Aitken M.L., Frazer D.A., Park D.R., Vaisar T., and Heinecke J.W. Spectral index for assessment of differential protein expression in shotgun proteomics. J. Proteome Res. 7 (2008) 845-854
17. Ghazalpour A., Doss S., Yang X., Aten J., Toomey E.M., Van Nas A., Wang S., Drake T.A., and Lusis A.J. Thematic review series: The pathogenesis of atherosclerosis. Toward a biological network for atherosclerosis. J. Lipid Res. 45 (2004) 1793-1805
18. Gordon S., and Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5 (2005) 953-964
19. Hegmans J.P., Bard M.P., Hemmes A., Luider T.M., Kleijmeer M.J., Prins J.B., Zitvogel L., Burgers S.A., Hoogsteden H.C., and Lambrecht B.N. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am. J. Pathol. 164 (2004) 1807-1815
20. Ishibashi S., Goldstein J.L., Brown M.S., Herz J., and Burns D.K. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93 (1994) 1885-1893
21. Keller A., Nesvizhskii A.I., Kolker E., and Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74 (2002) 5383-5392
22. Kersey P.J., Duarte J., Williams A., Karavidopoulou Y., Birney E., and Apweiler R. The International Protein Index: an integrated database for proteomics experiments. Proteomics 4 (2004) 1985-1988
23. Langer C., Huang Y., Cullen P., Wiesenhütter B., Mahley R.W., Assmann G., and von Eckardstein A. Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages. J. Mol. Med. 78 (2000) 217-227
24. Li A.C., Binder C.J., Gutierrez A., Brown K.K., Plotkin C.R., Pattison J.W., Valledor A.F., Davis R.A., Willson T.M., Witztum J.L., et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J. Clin. Invest. 114 (2004) 1564-1576
25. Li A.C., Brown K.K., Silvestre M.J., Willson T.M., Palinski W., and Glass C.K. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 106 (2000) 523-531
26. Li A.C., and Glass C.K. The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 8 (2002) 1235-1242
27. Linton M.F., Atkinson J.B., and Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 267 (1995) 1034-1037
28. Liu H., Sadygov R.G., and Yates III J.R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76 (2004) 4193-4201
29. Liu H., Zheng F., Li Z., Uribarri J., Ren B., Hutter R., Tunstead J.R., Badimon J., Striker G.E., and Vlassara H. Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme. Am. J. Pathol. 169 (2006) 303-313
30. Lusis A.J., Attie A.D., and Reue K. Metabolic syndrome: from epidemiology to systems biology. Nat. Rev. Genet. 9 (2008) 819-830
31. Maere S., Heymans K., and Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21 (2005) 3448-3449
32. Nesvizhskii A.I., Keller A., Kolker E., and Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75 (2003) 4646-4658
33. Old W.M., Meyer-Arendt K., Aveline-Wolf L., Pierce K.G., Mendoza A., Sevinsky J.R., Resing K.A., and Ahn N.G. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol. Cell. Proteomics 4 (2005) 1487-1502
34. Overton C.D., Yancey P.G., Major A.S., Linton M.F., and Fazio S. Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse. Circ. Res. 100 (2007) 670-677
35. Paul A., Chang B.H., Li L., Yechoor V.K., and Chan L. Deficiency of adipose differentiation-related protein impairs foam cell formation and protects against atherosclerosis. Circ. Res. 102 (2008) 1492-1501
36. Schadt E.E., and Lum P.Y. Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Reverse engineering gene networks to identify key drivers of complex disease phenotypes. J. Lipid Res. 47 (2006) 2601-2613
37. Simpson R.J., Jensen S.S., and Lim J.W. Proteomic profiling of exosomes: current perspectives. Proteomics 8 (2008) 4083-4099
38. Sokal R.R., and Rohlf F.J. Biometry: The principles and practice of statistics in biological research. Third Edition (1995), W.H. Freeman, New York
39. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Ueda O., Sakaguchi H., Higashi T., Suzuki T., et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386 (1997) 292-296
40. Vaisar T., Pennathur S., Green P.S., Gharib S.A., Hoofnagle A.N., Cheung M.C., Byun J., Vuletic S., Kassim S., Singh P., et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Invest. 117 (2007) 746-756
41. Wang Y.X., Martin-McNulty B., Huw L.Y., da Cunha V., Post J., Hinchman J., Vergona R., Sullivan M.E., Dole W., and Kauser K. Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E. Atherosclerosis 162 (2002) 23-31
42. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 115 (2005) 1111-1119